quinazolines has been researched along with Alveolitis, Fibrosing in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 13 (50.00) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Richeldi, L; Sgalla, G | 1 |
| Gao, YX; Jiang, LL; Li, XW; Zhang, Q; Zuo, DZ | 1 |
| Andrianifahanana, M; Becker, J; Edens, M; Gupta, SK; Leof, EB; Maidl, E; Rahimi, RA; Repellin, CE; Wilkes, MC; Wittenberger, J; Yin, X | 1 |
| Antony, V; Cai, GQ; Che, P; Desai, LP; Ding, Q; Han, X; Hu, M; Liu, G; Liu, RM; Luckhardt, T; O'Reilly, PJ; Siegal, GP; Thannickal, VJ; Zhou, Y | 1 |
| Chen, H; Han, R; He, Y; Huang, W; Li, K; Li, L; Lin, C; Lu, C; Sun, F; Wang, Y; Zhang, K | 1 |
| Azuma, A; Hagiwara, K; Kudoh, S | 1 |
| Ishihara, S; Minato, K; Mogi, A; Naito, Y; Saito, R; Shitara, Y; Suga, T; Takise, A; Tsuchiya, S; Yamabe, K | 1 |
| Katayama, H; Kishino, D; Kiura, K; Kuyama, S; Ohashi, K; Okada, T; Sato, K; Takigawa, N; Tanimoto, M | 1 |
| Davidson, CR; Hardie, WD; Ikegami, M; Korfhagen, TR; Le Cras, TD; Schmidt, SM; Whitsett, JA | 1 |
| Adachi, K; Chiba, S; Deki, T; Kawarada, S; Miyoshi, A; Mizoguchi, K; Suzuki, M | 1 |
| Chen, LA; Liang, ZX; Sun, JP; Tian, Q; Wang, P; Xu, SF; Yang, Z | 1 |
| Cai, L; Huang, WJ; Li, L; Li, WF; Yuan, WF | 1 |
| Azuma, A; Hoshino, T; Mizushima, T; Namba, T; Tanaka, K | 1 |
| Aono, Y; Hanibuchi, M; Kakiuchi, S; Kishi, J; Miyake, K; Nishioka, Y; Sone, S; Suzuka, C; Tani, K; Tezuka, T; Toyoda, Y; Yuasa, S | 1 |
| Breuer, R; Goldstein, RH; Or, R; Segel, MJ; Tzurel, A | 1 |
| Ouchi, Y; Teramoto, S; Yamamoto, H | 1 |
| Aoshiba, K; Nagai, A; Suzuki, H; Yokohori, N | 1 |
| Choe, JK; Cogswell, J; Kasimis, B; Nagaria, NC | 1 |
| Le Chevalier, T; Tsuboi, M | 1 |
| Fujimoto, S; Fukuda, T; Ishii, Y | 1 |
| Bach, JP; Faoro, C; Gorg, C; Kiessling, AM; Kleinhans, A; Neubauer, A; Riera-Knorrenschild, J; Schwella, N; Wagner, HJ | 1 |
| Kishi, K; Nakata, K; Yoshimura, K | 1 |
| Davidson, C; Hardie, WD; Ikegami, M; Korfhagen, TR; Le Cras, TD; Leikauf, GD; Prestridge, A; Whitsett, JA | 1 |
| Cotev, S; Feferman, R; Firman, N; Nagler, A; Pines, M; Shoshan, S | 1 |
| Nagler, A; Pines, M | 1 |
| Bonner, JC; Moomaw, CR; Morgan, DL; Rice, AB | 1 |
1 review(s) available for quinazolines and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Halofuginone: a novel antifibrotic therapy.
Topics: Animals; Collagen; Fibrosis; Humans; Liver Cirrhosis; Piperidines; Postoperative Complications; Protein Synthesis Inhibitors; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Skin; Tissue Adhesions | 1998 |
25 other study(ies) available for quinazolines and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Better to Be an Agnostic than a Believer (at Least in Pulmonary Fibrosis).
Topics: Antineoplastic Agents; Benzodioxoles; Humans; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; src-Family Kinases | 2022 |
[Rutaecarpine protects against bleomycin-induced pulmonary fibrosis through inhibiting Notch1/eIF3a signaling pathway in rats].
Topics: Animals; Bleomycin; Eukaryotic Initiation Factor-3; Indole Alkaloids; Male; Pulmonary Fibrosis; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Notch1; Signal Transduction | 2018 |
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases.
Topics: Animals; Benzamides; Bleomycin; Cell Line; Drug Interactions; Epidermal Growth Factor; ErbB Receptors; Feedback, Physiological; Imatinib Mesylate; Lapatinib; Lung; Mice; Myofibroblasts; Paracrine Communication; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pulmonary Gas Exchange; Pyrimidines; Quinazolines; Receptor, ErbB-2; Receptors, Platelet-Derived Growth Factor; Transforming Growth Factor beta; Up-Regulation | 2013 |
Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis.
Topics: Actins; Animals; Benzodioxoles; Cell Differentiation; Cell Line; Cells, Cultured; Collagen; Enzyme Inhibitors; Female; Humans; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Pulmonary Fibrosis; Quinazolines; src-Family Kinases; Transforming Growth Factor beta | 2014 |
Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway.
Topics: Animals; Antineoplastic Agents; Bleomycin; Blotting, Western; Epithelial-Mesenchymal Transition; Flow Cytometry; Gefitinib; Humans; Immunohistochemistry; Lung Diseases, Interstitial; Male; Metformin; Pulmonary Fibrosis; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta | 2015 |
Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients.
Topics: Acute Disease; Asian People; Gefitinib; Genetic Predisposition to Disease; Humans; Japan; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines | 2008 |
Impact of preexisting pulmonary fibrosis detected on chest radiograph and CT on the development of gefitinib-related interstitial lung disease.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Radiography, Thoracic; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed | 2008 |
Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice.
Topics: Animals; Antineoplastic Agents; Carcinogens, Environmental; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; ErbB Receptors; Female; Gefitinib; Lung; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrosamines; Pulmonary Fibrosis; Quinazolines; Smoking; Tumor Burden | 2009 |
Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.
Topics: Animals; Carrier Proteins; Collagen; Disease Models, Animal; Disease Progression; Doxycycline; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Regulation; Humans; Lung; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Quinazolines; Respiratory Mechanics; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transforming Growth Factor alpha; Uteroglobin | 2009 |
Effects of erlotinib on lung injury induced by intratracheal administration of bleomycin (BLM) in rats.
Topics: Animals; Bleomycin; Dogs; Erlotinib Hydrochloride; Humans; Hydroxyproline; Injections; Lung; Lung Injury; Neutrophils; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Rats; Trachea | 2010 |
Gefitinib attenuates murine pulmonary fibrosis induced by bleomycin.
Topics: Animals; Bleomycin; Blotting, Western; Collagen Type I; Collagen Type III; ErbB Receptors; Gefitinib; Male; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
[Gefitinib inhibits α-smooth muscle actin expression in mice with bleomycin-induced lung fibrosis].
Topics: Actins; Animals; Bleomycin; ErbB Receptors; Gefitinib; Lung; Male; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; Quinazolines; RNA, Messenger | 2010 |
Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis.
Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gefitinib; HSP70 Heat-Shock Proteins; Humans; Immunoblotting; Lung Diseases, Interstitial; Mice; Mice, Transgenic; MicroRNAs; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Real-Time Polymerase Chain Reaction | 2011 |
Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats.
Topics: Animals; Disease Models, Animal; ErbB Receptors; Gefitinib; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Radiation Pneumonitis; Rats; Rats, Wistar | 2012 |
Halofuginone does not reduce fibrosis in bleomycin-induced lung injury.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Bleomycin; Blotting, Northern; Bronchoalveolar Lavage Fluid; Cell Count; Collagen; Fibroblasts; Gene Expression Regulation; Hydroxyproline; Intubation, Intratracheal; Lung; Male; Piperidines; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; RNA; Transforming Growth Factor beta | 2002 |
Clinical efficacy and toxicity of gefitinib in patients with lung cancer.
Topics: Antineoplastic Agents; Gefitinib; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Pulmonary Fibrosis; Quinazolines; Radiography | 2003 |
Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis.
Topics: Animals; Bleomycin; Cell Division; Disease Models, Animal; ErbB Receptors; Gefitinib; Male; Mice; Mice, Inbred ICR; Phosphorylation; Pulmonary Fibrosis; Quinazolines | 2003 |
Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cough; Dyspnea; Fatal Outcome; Gefitinib; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pulmonary Fibrosis; Quinazolines | 2005 |
Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Incidence; Japan; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Risk Factors | 2006 |
Gefitinib prevents bleomycin-induced lung fibrosis in mice.
Topics: Animals; Bleomycin; Cell Culture Techniques; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblasts; Gefitinib; Humans; Male; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Tyrphostins | 2006 |
Pulmonary fibrosis in a patient treated with erlotinib.
Topics: Adult; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines | 2006 |
Efficacy of gefitinib in a patient with lung cancer associated with idiopathic pulmonary fibrosis.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines | 2006 |
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.
Topics: Animals; Bronchoalveolar Lavage Fluid; Doxycycline; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Gene Expression; Humans; Mice; Pulmonary Fibrosis; Quinazolines; RNA, Messenger; Transforming Growth Factor alpha | 2008 |
Reduction in pulmonary fibrosis in vivo by halofuginone.
Topics: Animals; Bleomycin; Collagen; Lung; Male; Piperidines; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Rats; Rats, Inbred Strains | 1996 |
Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.
Topics: Animals; Collagen; Enzyme Inhibitors; ErbB Receptors; Lung; Mitosis; Phosphorylation; Pulmonary Fibrosis; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Tyrphostins | 1999 |